Oncolytics Biotech Inc. (NASDAQ:ONCY) Financings

Oncolytics Biotech Inc.

Financings

RaiseDate
Common shares under equity line of credit (share purchase agreement)
Cancelled: raise
Buyers: Alumni (obligated to purchase up to US$20 million worth of common stock over a 15-month period); Alumni Capital
Use of proceeds: Funding to progress pelareorep's clinical development toward key clinical milestones
Aug 8, 2025
At-the-market programme of common shares
Cancelled: Cantor Fitzgerald
Dealers: Cantor Fitzgerald
Aug 8, 2025

Read by 6ix AI from the company's releases